Century Therapeutics Stock (NASDAQ: IPSC) stock price, news, charts, stock research, profile.
You can purchase shares of Century Therapeutics (NASDAQ:IPSC) through any online brokerage.
Other companies in Century Therapeutics’s space includes: Skye Bioscience (NASDAQ:SKYE), CytomX Therapeutics (NASDAQ:CTMX), Adverum Biotechnologies (NASDAQ:ADVM), bluebird bio (NASDAQ:BLUE) and Citius Oncology (NASDAQ:CTOR).
Century Therapeutics has a consensus price target of $11.75.
The stock price for Century Therapeutics (NASDAQ: IPSC) is $1.13 last updated January 3, 2025 at 7:32 PM EST.
There are no upcoming dividends for Century Therapeutics.
Century Therapeutics’s Q4 earnings are confirmed for Thursday, March 13, 2025.
There is no upcoming split for Century Therapeutics.
Century Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.